Table 1 Baselines characteristics
From: Prognostic value of systolic short-term blood pressure variability in systolic heart failure
N | 288 |
|---|---|
Age, years | 60 ± 12 |
Female, n (%) | 61 (21) |
BMI, Kg/m2 | 26 ± 4 |
NYHA class, n (%) | |
I | 16 (6) |
II | 137 (47) |
III | 122 (42) |
IV | 13 (5) |
Left Ventricular Ejection Fraction, % | 28 ± 9 |
Hypertension, n (%) | 125 (43) |
Diabetes, n (%) | 61 (21) |
Ischemic cardiomyopathy, n (%) | 131 (45) |
Primitive cardiomyopathy, n (%) | 123 (43) |
Valvular cardiomyopathy, n (%) | 13 (5) |
Congestive heart failure, n (%) | 123 (42) |
ACE inhibitors, n (%) | 239 (83) |
Beta-Blockers, n (%) | 179 (62) |
Spironolactone, n (%) | 141 (49) |